Article Versions Notes

Vlad R-A, Antonoaea P, Todoran N, Rédai E-M, Bîrsan M, Muntean D-L, Imre S, Hancu G, Farczádi L, Ciurba A. Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 2³-Factorial Design. Pharmaceutics. 2022; 14(7):1467. https://doi.org/10.3390/pharmaceutics14071467

Vlad, Robert-Alexandru, Paula Antonoaea, Nicoleta Todoran, Emöke-Margit Rédai, Magdalena Bîrsan, Daniela-Lucia Muntean, Silvia Imre, Gabriel Hancu, Lénárd Farczádi, and Adriana Ciurba. 2022. "Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 2³-Factorial Design" Pharmaceutics 14, no. 7: 1467. https://doi.org/10.3390/pharmaceutics14071467

Vlad, R.-A., Antonoaea, P., Todoran, N., Rédai, E.-M., Bîrsan, M., Muntean, D.-L., Imre, S., Hancu, G., Farczádi, L., & Ciurba, A. (2022). Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 2³-Factorial Design. Pharmaceutics, 14(7), 1467. https://doi.org/10.3390/pharmaceutics14071467